CLINICAL RESPONSE, EFFECTIVENESS, SAFETY AND MUCOSAL HEALING INDUCTION OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A PRELIMINARY REAL-LIFE MULTICENTRIC EXPERIENCE IN SOUTHERN ITALY

被引：0
|
作者：
Contaldo, A. [1 ]
Losurdo, G. [1 ]
Bossa, F. [2 ]
Biscaglia, G. [2 ]
Mazzuoli, S. [3 ]
Fanigliulo, L. [4 ]
Tursi, A. [5 ]
Lovero, R. [1 ]
Ierardi, E. [1 ]
Principi, M. B. [1 ]
Di Leo, A. [1 ]
机构：
[1] Univ Policlin Bari, UOC Gastroenterol, Bari, Italy
[2] Casa Sollievo Sofferenza, UOC Gastroenterol, San Giovanni Rotondo, Italy
[3] Osped S Nicola Pellegrino, UOC Gastroenterol, Trani, Italy
[4] SS Annunziata Hosp, Gastroenterol Unit, Taranto, Italy
[5] ASL BAT, Gastroenterol Serv, Barletta, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2018年 / 50卷 / 02期
关键词：
D O I：
10.1016/S1590-8658(18)30562-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P.07.12
引用
收藏
页码：E198 / E198
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience
    Kopylov, Uri
    Ron, Yulia
    Avni-Biron, Irit
    Koslowsky, Benjamin
    Waterman, Matti
    Daher, Saleh
    Ungar, Bella
    Yanai, Henit
    Maharshak, Nitsan
    Ben-Bassat, Ofer
    Lichtenstein, Lev
    Shitrit, Ariella Bar-Gil
    Israeli, Eran
    Schwartz, Doron
    Zittan, Eran
    Eliakim, Rami
    Chowers, Yehuda
    Ben-Horin, Shomron
    Dotan, Iris
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (03) : 404 - 408
  • [22] Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety
    Christensen, Britt
    Colman, Ruben J.
    Micic, Dejan
    Gibson, Peter R.
    Goeppinger, Sarah R.
    Yarur, Andres
    Weber, Christopher R.
    Cohen, Russell D.
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (04) : 849 - 860
  • [23] EVALUATION OF CONCOMITANT CORTICOSTEROID AND VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN REAL-LIFE CLINICAL PRACTICE
    Ylisaukko-Oja, T.
    Torvinen, S.
    Aaltonen, J.
    Vihervaara, V.
    Eberl, A.
    Nuutinen, H.
    Blomster, T.
    Jussila, A.
    Pajala, M.
    Jokelainen, J.
    Herrala, S.
    Tamminen, K.
    Sipponen, T.
    VALUE IN HEALTH, 2017, 20 (05) : A180 - A180
  • [24] Evaluation of treatment persistence of vedolizumab among Finnish inflammatory bowel disease patients in real-life clinical practice (FINVEDO)
    Ylisaukko-oja, T.
    Eberl, A.
    Aaltonen, J.
    Nuutinen, H.
    Blomster, T.
    Jussila, A.
    Pajala, M.
    Jokelainen, J.
    Herrala, S.
    Tamminen, K.
    Sipponen, T.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S342 - S342
  • [25] Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of inflammatory bowel disease: the elderly cohort
    Pugliese, D.
    Privitera, G.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S419 - S420
  • [26] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT
    Pugliese, Daniela
    Privitera, Giuseppe
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2021, 160 (06) : S43 - S43
  • [27] Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Jenkins, Sarah M.
    Park, Sang Hyoung
    Aniwan, Satimai
    Schoenoff, Shayla A.
    Bruining, David H.
    Papadakis, Konstantinos A.
    Raffals, Laura
    Tremaine, William J.
    Loftus, Edward V.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (03) : 580 - 586
  • [28] Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center
    Dragoni, Gabriele
    Bagnoli, Siro
    Le Grazie, Marco
    Campani, Claudia
    Rogai, Francesca
    Manetti, Natalia
    Bensi, Carolina
    Macri, Giuseppe
    Galli, Andrea
    Milla, Monica
    JOURNAL OF DIGESTIVE DISEASES, 2019, 20 (05) : 235 - 242
  • [29] Drug levels of VEDOLIZUMAB in patients with pediatric-onset inflammatory bowel disease in a real-life setting
    Hemming-Harlo, Maria
    Merras-Salmio, Laura
    Nikkonen, Anne
    Kolho, Kaija-Leena
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (01) : 313 - 322
  • [30] Drug levels of VEDOLIZUMAB in patients with pediatric-onset inflammatory bowel disease in a real-life setting
    Maria Hemming-Harlo
    Laura Merras-Salmio
    Anne Nikkonen
    Kaija-Leena Kolho
    European Journal of Pediatrics, 2024, 183 : 313 - 322
12345